Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · Real-Time Price · USD
4.020
+0.280 (7.49%)
At close: Sep 26, 2025, 4:00 PM EDT
4.040
+0.020 (0.50%)
After-hours: Sep 26, 2025, 7:50 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022
Period Ending
Dec '23 Dec '22
Novel Therapies
675.00K
Log In
Novel Therapies Growth
-29.02%
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022
Period Ending
Dec '23 Dec '22
United States
675.00K
Log In
United States Growth
-29.02%
Log In